Marsh & McLennan results disappoint, shares drop

Wed Nov 5, 2008 6:00pm EST
 
[-] Text [+]

* CEO says credit mkt woes hamper divestitures

* Analysts see longer road for MMC turnaround

* Adjusted profit $O.21/shr, misses Wall Street view

* Shares fall as much as 13 percent

(Adds analyst comment)

By Lilla Zuill

NEW YORK (Reuters) - U.S. insurance broker Marsh & McLennan Cos Inc (MMC.N) posted third-quarter results that missed Wall Street expectations, as it lost money on investments and increased its liability reserves, sending its shares down as much as 13 percent.

Investors had hoped for a repeat of the better-than-expected results reported a quarter ago, a bright spot for Marsh & McLennan after several years of flagging profitability.

"There were a lot of moving parts, and it was a bit messy," said Chief Executive Brian Duperreault, installed earlier this year to improve the company's fortunes. But he pointed to the strength of the firm's underlying earnings.

"The investment swing was significant, and somewhat out of our control. Strip that out, and other one-time notables, and income was up significantly," Duperreault said in an interview.

The company reported a net loss of $8 million, or 2 cents a share, compared with a year-earlier profit of $1.9 billion, when Marsh & McLennan benefited from a one-time sales gain.

Increasing its professional-liability reserves cost about 4 cents a share, and investment losses from market declines on private equity investments another 3 cents a share.

Excluding special items, the company earned $111 million, or 21 cents per share -- a 10 percent increase from the $100 million, or 19 cents a share, in the year-ago quarter, but missing Wall Street's average expectations by 11 cents per share.

"Despite management's best efforts to put a positive spin on third-quarter earnings release, the results were quite discouraging," said Friedman, Billings, Ramsey analyst Bijan Moazami, in a note to clients.

"The market is beginning to realize that even if management effectively executes on cost initiatives, the improvement in profit margins will take time to materialize," Moazami added.

He cut his price target on the stock to $25, below its closing price on Wednesday of $26.06, down 12.26 percent.  Continued...

 
Actors Vincent Curatola (L), Steven Van Zandt (C) and Tony Sirico from "The Sopranos" arrive at the 14th annual Screen Actors Guild Awards in Los Angeles January 27, 2008. REUTERS/Mario Anzuoni
Wall St meets "The Sopranos"

Details of an alleged insider trading ring read like the script of a mobster drama, full of coded nicknames, disposable cell phones and paranoia about informants. But in the end, all of the precautions were for naught.  Full Article 

Featured Broker sponsored link

REUTERS/Chip East
Insider sales not a sell signal this time

Corporate bosses are likely to sell more of their companies' stock through the end of the year, but that does not mean stock prices have reached a peak.  Full Article